Why EBNI?
Traditional nipple reconstruction loses projection over time and does not offer dynamic or responsive behavior. Many survivors express dissatisfaction with current static solutions.
The EBNI system introduces controlled projection motion, internal sensing, and future potential for enhanced reconstructive outcomes.
Key Goals
- Long-term projection stability
- Controlled motion and responsiveness
- Engineering foundation for sensory research
- Compatibility with existing surgical workflows
The Technology
EBNI integrates microelectronics, actuators, sensors, and wireless systems inside a soft implantable structure designed to replicate natural appearance and movement.
Core Implant
A silicone outer shell contains a miniature actuator, internal circuitry, and pressure-interaction sensing components.
Wireless Power & Control
The implant charges wirelessly and communicates via encrypted BLE, enabling configuration without physical ports.
Software Ecosystem
A clinician-facing app supports projection control, diagnostics, and future firmware updates.
System Overview
- Embedded ESP32-class microcontroller
- Miniature linear actuator
- Pressure / interaction sensing
- Rechargeable LiPo battery
- Wireless charging interface
- BLE communication
Future Capabilities
- Sensory mapping research
- Clinical dashboards
- Adaptive projection profiles
For Patients & Survivors
EBNI is being developed for individuals seeking a more natural, responsive nipple reconstruction outcome.
Important: EBNI is under early-stage R&D and is not approved for clinical use.
What We’re Working Toward
- Stable and lasting projection
- Natural appearance and motion
- Optional involvement in sensory studies
- Clear safety and consent frameworks
For Surgeons & Clinical Partners
OctoNerv is partnering with surgical teams to refine implant design, workflow, and usability for clinical studies.
Co-Design
Collaborate to optimize implantation workflow and interface options.
Research Collaboration
Participate in preclinical testing and early feasibility research.
Industry Partnerships
Open to manufacturing, molding, materials, and compliance partners.
Development Roadmap
Phase 1 – Electronic Prototype ✔
Bench testing validated actuator control, BLE, and wireless charging.
Phase 2 – Preclinical Form Factor
Integrating electronics into silicone housing; mechanical validation underway.
Phase 3 – Regulatory Pathway
Risk assessment and standards alignment prior to feasibility studies.
Phase 4 – First-in-Human Studies
Controlled pilot evaluations at selected clinical centers.
Contact OctoNerv
If you are a clinician, partner, investor, or research institution interested in collaboration, we welcome your inquiry.
- Email: steven@octonervs.com
- Website: octonervs.com
Quick Inquiry
Please include:
- Your name & organization
- Your role
- Your collaboration interest
Disclaimer: The Electronic Breast Nipple Implant (EBNI) is an early-stage investigational concept. It is not approved for clinical use by any regulatory authority.